PharmaBiome AG

PharmaBiome AG is a pioneer in the development and production of live biotherapeutic products to address disturbances of the gut microbiome. An ETH Spin Off, we were founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science. We believe that the future of microbiome-based therapeutics lies in the development of the biotechnology necessary to produce human medicines. This holds the promise of becoming a first step into the creation of personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs.